Controversies in Precision Medicine - 2017 Lecture Titles

2017 Lecture Titles

We are pleased to share with you all our recoreded presentations from 2017, so you can catch-up on all the debate you missed.

THE DEBATE:
CONTROVERSIES IN PRECISION MEDICINE
Debater:
Richard Fitzgerald, Director, Clinical Research Unit, RLUH, Liverpool, UK
Debater: 
Denis Noble, Emeritus Professor of Cardiovascular Physiology, Oxford, UK

ACCESS ALL SESSIONS HERE


BUSINESS PERSPECTIVE
New Business Models for New Drugs



Christian Elze, Senior Partner Catenion, London, UK
Biomarker-Driven Oncology Drug Development: From Pharmaceutical Giants to a Start-Up Biotech

Robert Wasserman, Chief Medical Officer at Northern Biologics, Toronto, Canada 

ACCESS ALL SESSIONS HERE


PRECISION MEDICINE - THE PHARMACEUTICAL STANDPOINT

Preventing Cancer – Turning a Challenge into Unprecedented Opportunity

Thomas Bock, Chairman and Chief Executive Officer HeritX, Santa Monica, USA
Biomarkers in Oncology Drug Development

Matthias Ocker, Head of Biomarker Strategy, Bayer AG, Berlin, Germany 

Novel RNA-Based Cancer Immunotherapies

Prof. Dr. Manfred Dietel, Full Professor and Director of the Institute of Pathology, University Hospital Charité, Berlin, Germany
PRECISION MEDICINE IN 
THE CLINIC - CLINICAL STANDPOINT

Molecular Tests in the Clinic: Where Do We Stand in 2017?


Prof. Ido Wolf, Head, Oncology Division, Tel Aviv Medical Center, Tel Aviv, Israel
Personalized Medicine in Chronic Myeloid Leukemia (CML) in 2018 – Does It Exist? A Clinician's Perspective

Prof. Pia Raanani, Head, Hematology Division, Davidoff Cancer Center, Rabin Medical Center
Precision Oncology 2018: Bridging Targeted Treatments and Immunotherapy

Prof. Ulrich Keilholz, Acting Director, Charité Comprehensive Cancer Center, Berlin, Germany

ACCESS ALL SESSIONS HERE


PATIENT STRATIFICATION VIA GENOMICS/EPI-GENOMICS IN CANCER

RNA Editing - Common, Hidden Cancer Mutations

Prof. Erez Levanon, Associate Professor at The Mina and Everard Faculty of Life Sciences, Bar-Ilan University Ramat Gan, Israel

ACCESS ALL SESSIONS HERE


GENOMICS IN PRECISION MEDICINE. CLINICAL INFORMATICS

Clinical Bioinformatics in Lung Diseases



Prof. Xiangdong Wang, Director Shanghai Institute Clinical Bionformatics, Fudan University Zhongshan Hospital, Shanghai, China
Clinical and Genomic Context in Druggable Targets and Refining the Evidence Base

Dr. Deepak Asudani, Associate Clinical Professor of Medicine, Vice Chief, Clinical Operations, Division of Hospital Medicine, University of California San Diego, USA

DEVELOPING NEW DELIVERY VEHICLES FOR PRECISION MEDICINE

Engineering Nanomedicines for RNA Delivery in Tumor Immunotherapy

Dr Heinrich Haas, Vice President RNA Formulation & Drug Delivery at BioNTech RNA Pharmaceuticals, Mainz, Germany
Rapid Development and Scalable Manufacture of Precision Nanomedicines

Dr James Taylor, Co-founder, CEO at Precision NanoSystems, Inc., Vancouver, Canada

Towards Precision Nanomedicine

Dr Twan Lammers, Head of department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany

ACCESS ALL SESSIONS HERE


THE FUTURE OF PRECISION MEDICINE FROM A REGULATORY STANDPOINT

Regulatory Considerations of the Use of Next Generation Sequencing and Biomarkers to Support the Implementation of Precision Medicine

Dr Khaled Bouri, Senior Science Advisor to the Director of the Office of Regulatory Science Innovation & Critical Path Initiatives, FDA, USA
The role of Innovate UK in the development of Precision Medicine



Dr Christopher Rowe, Innovation Lead, Precision Medicine, Innovate UK, Swindon, UK

Filtering Big Data, Finding Small Molecules, that Lead to Precision Medicine in Breast Cancer

Prof. Noam Shomron, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

HEALTH INFORMATICS

Patient Centricity in The Era of Data-Driven Value-Based Precision Medicine



Dr Harsha Rajasimha, Global Head, Life Sciences R&D, NTT DATA Inc., Washington, USA
Identifying Non-Coding Variants that Cause Rare Disorders: Opening a Window to the Rest of the Genome in Variant Detection Analyses

Dr Sahar Gelfman, Research Associate at Institute for Genomic Medicine, Columbia University Medical Center, New York, USA

ACCESS ALL SESSIONS HERE

THE POWER OF PRECISION MEDICINE IN RARE DISEASE

Precision Medicine for Cystic Fibrosis: Each Genotype Defines New Therapeutic Opportunities

Dr Janet Allen, Director of Strategic Innovation at Cystic Fibrosis Trust, London, UK
Living with a Child with a Rare Disorder and Advancing Research for a Cure


Lior Dor, Founder of Ran’s smile – the Israeli STXBP1 foundation, Rehovot, Israel

ACCESS ALL SESSIONS HERE


NEW THERAPEUTIC MODALITIES FOR RARE DISEASE

Modified mRNA Therapeutics for Rare Diseases



Dr Eran Blaugrund, Vice President Research and Development, ART BioScience Ltd., Rehovot, Israel
How Rare Disease, Omics and AI can Help to Identify New Drug Targets or Nutraceuticals for Chronic Inflammatory Conditions

Dr Thomas Wilckens,CEO at InnVentis Ltd., Kadima, Israel


Keep Me Updated